Companies / United Arab Emirates
If you would like to subscribe to Middle East & Africa Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Middle East & Africa Pharma & Healthcare Insight please click on the trial link below.
Julphar Posts Strong Results In H108
August 2008 | Industry NewsSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Middle East & Africa Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Middle East & Africa Pharma & Healthcare Insight please click on the trial link below.
Julphar's total revenue in H108 increased by 14.4% year-on-year (y-o-y) to reach AED308.5mn (US$84mn), while its net profits increased by 96% to AED122.2mn (US$33.3mn) during the same period. Julphar sold its subsidiaries Julphar Drug Store (Pharmacies Division), and Oman and Fujairah Medical Trading Company to Planet Pharmacies in H108.